Rallybio Corporation (RLYB) Tops Q3 EPS by 56c

Rallybio Corporation (NASDAQ: RLYB) reported Q3 EPS of $0.36, $0.56 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• U.S., Canada discussing possible reduction in U.S. autos tariffs to 15% after some value content deductions from 25% currently - Reuters
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'